The advantages of Faecalibacterium prasnitzii in gestational diabetes mellitus
- 27 June 2025
- journal article
- review article
- Published by Taylor & Francis in Future Microbiology
- Vol. 20 (10) , 695-706
Abstract
In recent years, the incidence of metabolic disorders has exponentially increased worldwide mainly due to the misfunctioning of chemical reactions. Gestational diabetes mellitus (GDM) occurred during pregnancy when placenta prevent absorption of sufficient insulin in mother's body. Although this disorder usually disappears after delivery, it could raise the probability of developing complications in the future. GDM is associated with adverse effects on women and their children, such as obesity, cardiovascular disease, and type 2 diabetes. On the other hand, administration of probiotics as a live microorganism with the wide array of health values could contribute to restore and stabilize gut microbiota and subsequently regulate essential internal functions such as development of immunity. In this review, we focus primarily on some causes and effects of GDM in pregnant women and then Faecalibacterium prasnitzii, the most abundant butyrate-producing bacterium in gut, which have been using as a prominent biomarker in health and disease and also potential anti-inflammatory treatment owing to the production of active molecules.Keywords
This publication has 98 references indexed in Scilit:
- Maternal Intake of Probiotics to Program Offspring HealthCurrent Nutrition Reports, 2022
- Alterations of gut microbiota‐derived metabolites in gestational diabetes mellitus and clinical significanceJournal of Clinical Laboratory Analysis, 2022
- Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthmaAllergologia et Immunopathologia, 2019
- Microbiome and its relation to gestational diabetesEndocrine, 2018
- Diabetes during pregnancy influences Hofbauer cells, a subtype of placental macrophages, to acquire a pro-inflammatory phenotypeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Assessment of the number and function of macrophages in the placenta of gestational diabetes mellitus patientsCurrent Medical Science, 2013
- Intestinal microbiota in human health and disease: the impact of probioticsGenes & Nutrition, 2011
- Toll like receptor 4 in atherosclerosis and plaque destabilizationAtherosclerosis, 2010
- Low counts of Faecalibacterium prausnitzii in colitis microbiotaInflammatory Bowel Diseases, 2009
- Inflammatory markers in women with a recent history of gestational diabetes mellitusJournal of Endocrinological Investigation, 2005